相关实验视频

Updated: Jul 16, 2025

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

重定向GPS指导免疫疗法在子宫内膜癌

Rhea Jangra¹, Neesha C Dhani¹

¹Princess Margaret Cancer Centre, Division of Medical Oncology and Hematology, Toronto, Ontario, Canada.

Clinical cancer research : an official journal of the American Association for Cancer Research

|September 12, 2023

概括

仅仅不匹配修复 (MMR) 状态不足以指导对子宫内膜癌的PD-(L) 1治疗. 像瘤突变负担这样的生物标志物可以帮助选择单一治疗或组合策略的患者.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
基因组学就是基因组学.

背景情况:

子宫内膜癌的治疗正在与免疫疗法一起发展.
不匹配修复 (MMR) 缺陷是PD-L1抑制剂的已知预测标记.
然而,单靠MMR状态可能无法完全预测所有患者的反应.

研究的目的:

评估MMR状态在指导子宫内膜癌PD-(L) 1单疗中的充分性.
探索额外的生物标志物,可以改进患者选择免疫疗法.

主要方法:

在子宫内膜癌患者的MMR状态的分析.
评估其他生物标志物,如瘤突变负担 (TMB) 和综合阳性得分 (CPS).
生物标志物状态与对PD-(L) 1单一治疗的反应的相关性.

主要成果:

单独的MMR状态不足以指导PD-(L) 1单疗决策.
瘤突变负担和CPS可以确定可能受益于单一治疗的MMR熟练患者.
这些生物标志物还可以帮助分层那些可能需要组合治疗的MMR缺乏症患者.

结论:

除了MMR状态之外,综合生物标志物方法对于优化子宫内膜癌PD-L) 1治疗至关重要.
根据MMR,TMB和CPS定制治疗可以改善患者的治疗结果.
需要进一步的研究来验证这些发现并指导临床实践.

更多相关视频

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...